LEVOLET (levothyroxine sodium) by Pfizer is synthesis. First approved in 2003.
Drug data last refreshed 12h ago · AI intelligence enriched 4d ago
LEVOLET is a Pfizer oral tablet containing levothyroxine sodium, a synthetic thyroid hormone replacement used to treat hypothyroidism and other thyroid disorders. The drug works by diffusing into cell nuclei and binding to thyroid receptor proteins, activating gene transcription and protein synthesis. Physiological effects are primarily mediated by T3, approximately 80% of which is derived from peripheral conversion of the T4 component.
Mature, established product at peak lifecycle with stable demand; brand team likely focused on patient retention and physician education rather than market expansion.
synthesis. Triiodothyronine (T 3 ) and levothyroxine (T 4 ) diffuse into the cell nucleus and bind to thyroid receptor proteins attached to DNA. This hormone nuclear receptor complex activates gene transcription and synthesis of messenger RNA and cytoplasmic proteins. The physiological actions of…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
Fasting Study of Levothyroxine Sodium Tablets 300 mcg to Synthroid® Tablets 300 mcg
Fasting Study of Levothyroxine Sodium Tablets 300 μg to Levothroid® Tablets 300 μg
Worked on LEVOLET at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on LEVOLET offers stable, long-term career continuity in a mature thyroid replacement therapy franchise with predictable patient demand and established physician relationships. However, limited clinical innovation and approaching LOE mean career growth is likely tied to geographic expansion, dosing convenience improvements, or transition to brand lifecycle management skills.